Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy
Open Forum Infectious Diseases · 26.11.2025 · 12 (12)
DOI: 10.1093/ofid/ofaf696 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 28.11.2025. Verfasst von Todd Hulgan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University Medical Center, Nashville, Tennessee, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NCATS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Given the melanocortin-4 receptor's (MC4R) importance in obesity, we examined associations between MC4R gene variants and weight following a switch to integrase inhibitor-containing antiretroviral therapy among participants in Advancing Clinical Therapeutics Globally studies. Among 529 persons with HIV (median age: 50 years, 29% non-Hispanic Black, 22% female), 62% were overweight or obese at integrase strand transfer inhibitor switch, and 62% switched to raltegravir. In adjusted linear models, three variants were associated (P < .05) with weight change after switch in all participants or in prespecified subgroups. These exploratory findings are consistent with the role of melanocortins in appetite and weight and suggest a neuroendocrine contribution to integrase inhibitor-related weight gain.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- University of Colorado, Aurora, Colorado, USA.
- University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
- University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Johns Hopkins University, Baltimore, Maryland, USA.
ORCID-Profile: Todd Hulgan, Kristine M Erlandson, Sara H Bares, Todd T Brown, Jordan E Lake, Marylyn D Ritchie, John R Koethe
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- National Center for Research Resources
- National Center for Advancing Translational Sciences
- Tennessee Center for AIDS Research
- ACTG
Zitieren
APA
Hulgan, T., Erlandson, K. M., Bradford, Y., Tassiopoulos, K., Wu, K., Bares, S. H., Brown, T. T., Lake, J. E., Leonard, M., McComsey, G. A., Ritchie, M. D., Sax, P. E., Koethe, J. R., & Haas, D. W. (2025). Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy. Open Forum Infectious Diseases, 12(12). https://doi.org/10.1093/ofid/ofaf696
Vancouver
Hulgan T, Erlandson KM, Bradford Y, Tassiopoulos K, Wu K, Bares SH, et al. Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy. Open Forum Infectious Diseases. 2025;12(12). doi:10.1093/ofid/ofaf696
BibTeX
@article{Hulgan2025,
author = {Hulgan, Todd and Erlandson, Kristine M and Bradford, Yuki and Tassiopoulos, Katherine and Wu, Kunling and Bares, Sara H and Brown, Todd T and Lake, Jordan E and Leonard, Michael and McComsey, Grace A and Ritchie, Marylyn D and Sax, Paul E and Koethe, John R and Haas, David W},
title = {Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy},
journal = {Open Forum Infectious Diseases},
year = {2025},
volume = {12},
number = {12},
doi = {10.1093/ofid/ofaf696}
}
EUVIMED